149 related articles for article (PubMed ID: 15132179)
1. Optimization of biodegradable sponges as controlled release drug matrices. I. Effect of moisture level on chitosan sponge mechanical properties.
Foda NH; El-laithy HM; Tadros MI
Drug Dev Ind Pharm; 2004 Apr; 30(4):369-79. PubMed ID: 15132179
[TBL] [Abstract][Full Text] [Related]
2. Implantable biodegradable sponges: effect of interpolymer complex formation of chitosan with gelatin on the release behavior of tramadol hydrochloride.
Foda NH; El-laithy HM; Tadros MI
Drug Dev Ind Pharm; 2007 Jan; 33(1):7-17. PubMed ID: 17192246
[TBL] [Abstract][Full Text] [Related]
3. Polymeric matrix system for prolonged delivery of tramadol hydrochloride, part I: physicochemical evaluation.
Ammar HO; Ghorab M; El-Nahhas SA; Kamel R
AAPS PharmSciTech; 2009; 10(1):7-20. PubMed ID: 19132537
[TBL] [Abstract][Full Text] [Related]
4. Influence of the acid type on the physical and drug liberation properties of chitosan-gelatin sponges.
Leffler CC; Müller BW
Int J Pharm; 2000 Jan; 194(2):229-37. PubMed ID: 10692647
[TBL] [Abstract][Full Text] [Related]
5. [The delivery mechanism of micro-porous osmotic pump tablets].
Zhao XL; Li Q; Gong XF; Li SM
Yao Xue Xue Bao; 2007 Feb; 42(2):226-30. PubMed ID: 17518057
[TBL] [Abstract][Full Text] [Related]
6. Chitosan-genipin microspheres for the controlled release of drugs: clarithromycin, tramadol and heparin.
Harris R; Lecumberri E; Heras A
Mar Drugs; 2010 May; 8(6):1750-62. PubMed ID: 20631867
[TBL] [Abstract][Full Text] [Related]
7. The preparation and characterisation of drug-loaded alginate and chitosan sponges.
Lai HL; Abu'Khalil A; Craig DQ
Int J Pharm; 2003 Jan; 251(1-2):175-81. PubMed ID: 12527187
[TBL] [Abstract][Full Text] [Related]
8. Exploiting polymer blending approach for fabrication of buccal chitosan-based composite sponges with augmented mucoadhesive characteristics.
Freag MS; Saleh WM; Abdallah OY
Eur J Pharm Sci; 2018 Jul; 120():10-19. PubMed ID: 29715500
[TBL] [Abstract][Full Text] [Related]
9. Tramadol loading, release and iontophoretic characteristics of ion-exchange fiber.
Gao Y; Yuan J; Liu H; Yang Y; Hou Y; Li S
Int J Pharm; 2014 Apr; 465(1-2):102-11. PubMed ID: 24530391
[TBL] [Abstract][Full Text] [Related]
10. Tissue engineered bone formation using chitosan/tricalcium phosphate sponges.
Lee YM; Park YJ; Lee SJ; Ku Y; Han SB; Choi SM; Klokkevold PR; Chung CP
J Periodontol; 2000 Mar; 71(3):410-7. PubMed ID: 10776928
[TBL] [Abstract][Full Text] [Related]
11. A non-covalently cross-linked chitosan based hydrogel.
Noble L; Gray AI; Sadiq L; Uchegbu IF
Int J Pharm; 1999 Dec; 192(2):173-82. PubMed ID: 10567748
[TBL] [Abstract][Full Text] [Related]
12. Sugar-mediated chitosan/poly(ethylene glycol)-beta-dicalcium pyrophosphate composite: mechanical and microstructural properties.
Wang JW; Hon MH
J Biomed Mater Res A; 2003 Feb; 64(2):262-72. PubMed ID: 12522813
[TBL] [Abstract][Full Text] [Related]
13. Lyophilized sustained release mucoadhesive chitosan sponges for buccal buspirone hydrochloride delivery: formulation and in vitro evaluation.
Kassem MA; ElMeshad AN; Fares AR
AAPS PharmSciTech; 2015 Jun; 16(3):537-47. PubMed ID: 25370025
[TBL] [Abstract][Full Text] [Related]
14. Sustained release chitosan microspheres prepared by novel spray drying methods.
He P; Davis SS; Illum L
J Microencapsul; 1999; 16(3):343-55. PubMed ID: 10340219
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of ionotropic cross-linked chitosan/gelatin B microspheres of tramadol hydrochloride.
Basu SK; Kavitha K; Rupeshkumar M
AAPS PharmSciTech; 2011 Mar; 12(1):28-34. PubMed ID: 21161459
[TBL] [Abstract][Full Text] [Related]
16. Aqueous preparation and evaluation of albumin-chitosan microspheres containing indomethacin.
Bayomi MA
Drug Dev Ind Pharm; 2004 Apr; 30(4):329-39. PubMed ID: 15132175
[TBL] [Abstract][Full Text] [Related]
17. Preparation and evaluation of sustained release cross-linked chitosan microspheres containing phenobarbitone.
al-Helw AA; Al-Angary AA; Mahrous GM; al-Dardari MM
J Microencapsul; 1998; 15(3):373-82. PubMed ID: 9608399
[TBL] [Abstract][Full Text] [Related]
18. Controlled drug delivery systems based on thiolated chitosan microspheres.
Elhassan Imam M; Bernkop-Schnürch A
Drug Dev Ind Pharm; 2005 Jul; 31(6):557-65. PubMed ID: 16109629
[TBL] [Abstract][Full Text] [Related]
19. Chitosan and chondroitin microspheres for oral-administration controlled release of metoclopramide.
Ganza-González A; Anguiano-Igea S; Otero-Espinar FJ; Blanco Méndez J
Eur J Pharm Biopharm; 1999 Sep; 48(2):149-55. PubMed ID: 10469933
[TBL] [Abstract][Full Text] [Related]
20. Chitosan and sodium sulfate as excipients in the preparation of prolonged release theophylline tablets.
Alsarra IA; El-Bagory I; Bayomi MA
Drug Dev Ind Pharm; 2005 May; 31(4-5):385-95. PubMed ID: 16093204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
